Long term follow up of men with Alfuzosin who voided successfully following acute urinary retention

International Urology and Nephrology

Volumn 37, Issue 3, 2005, Pages 507-510

  Palit, Victor ^a   Shah, T ^a   Biyani, C S ^a   Elmasry, Y ^a   Sarkar, R ^a   Flannigan, G M ^a   Puri, R ^a  

^a ST LUKE S HOSPITAL   (United Kingdom)

Author keywords

blockers; Acute urinary retention; Trial without catheter

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO;

ACUTE DISEASE; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; MICTURITION; RESIDUAL URINE; SYMPTOMATOLOGY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE FLOW RATE; URINE RETENTION;

ACUTE DISEASE; ADRENERGIC ALPHA-ANTAGONISTS; FOLLOW-UP STUDIES; HUMANS; MALE; QUALITY OF LIFE; QUINAZOLINES; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT FAILURE; URINARY RETENTION;

EID: 28844486653     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-004-4709-1     Document Type: Article

References (14)

1. SJ Jacobsen DJ Jacobsen CJ Girman et al. 1997 Natural history of prostatism: Risk factors for acute urinary retention J Urol 158 481-487 9224329 1:STN:280:ByiA28jmt1I%3D
2. R Pickard M Emberton DE. Neal 1998 The management of men with acute urinary retention Brit J Urol 81 712-720 9634047 1:STN:280:DyaK1c3psFyjtg%3D%3D
3. CP Chilton RJ Morgan HR England et al. 1978 A critical evaluation of the results of transurethral resection of the prostate Br J Urol 50 542-546 88983 1:STN:280:CSaB3szkslc%3D
4. WK Mebust HL Holtgrewe ATK Cockett PC. Peters 1989 Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of participating institutions evaluating 3885 patients J Urol 141 243-247 2643719 1:STN:280:BiaC3M7hsFY%3D
5. KB Lim MYC Wong KT. Foo 1999 The outcome of trial of catheter after acute retention of urine Ann Acad Med 28 516-518 1:STN:280:DC%2BD3c%2FisVCjtQ%3D%3D
6. T Shah V Palit S Biyani et al. 2002 Randomised, placebo controlled. Double blind study of Alfuzosin SR in patients undergoing trial without catheter following acute urinary retention Eur Urol 42 329-332 10.1016/ S0302-2838(02)00319-6 12361896 1:CAS:528:DC%2BD38XovVCksr8%3D
7. R Hartung 2001 Do α-blockers prevent the occurrence of acute urinary retention? Eur Urol 39 Suppl6 13-18 11306896 1:CAS:528:DC%2BD3MXktF2rtLo%3D
8. Jardin A, Bensadoun H, Attali P, and the BPH-ALF group: Alfuzosin for the treatment of benign prostatic hypertrophy. Lancet 1991; 337: 1457-1461.
9. G Martorana C Giberti F Silverio Di et al. 1997 Effects of short term treatment with the α1 blocker Alfuzosin on urodynamic pressure/ flow parameters in patients with benign prostatic hyperplasia Eur Urol 32 47-53 9266231 1:CAS:528:DyaK1cXlt1Wgur8%3D
10. SA. Mcneill 2004 The role of alpha-blockers in the management of Acute Urinary Retention caused by benign prostatic obstruction Eur Urol 45 325-332 1:CAS:528:DC%2BD2cXisVWmur4%3D
11. SA McNeill PD Daruwala IDC Mitchell et al. 1999 Sustained-release Alfuzosin and trial without catheter after urinary retention: A prospective, placebo-controlled trial BJUI 84 622-627 1:CAS:528:DyaK1MXmvVyqsLk%3D
12. SA. Mcneill 2001 Does acute urinary retention respond to alpha-blockers alone? Eur Urol 39 Suppl 6 7-12 11306895 1:CAS:528:DC%2BD3MXktF2rtL0%3D
13. JD McConnell GC Roehrborn et al. 2003 The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign Prostatic hyperplasia New Engl J Med 349 2387-2398 10.1056/ NEJMoa030656 14681504 1:CAS:528:DC%2BD3sXpvFGqt7s%3D
14. A Mcneill A Naadimthu T Hargreave 2003 the ALFAUR study group Alfuzosin 10mg once daily in the management of acute urinary retention-preliminary results of alfaur study Eur Urol Suppl 2 1 7510.1016/ S1569-9056(03)80297-X Abstract 291